Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1998
11/18/1998EP0878194A1 Remedies or preventives for aids
11/18/1998EP0877812A1 Antibodies and immunoglobulin fusion proteins having modified effector functions and uses therefor
11/18/1998EP0877809A1 TOXOPLASMA GONDII ANTIGEN Tg20
11/18/1998EP0877806A1 Nucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereof
11/18/1998EP0877804A1 Inhibitors of cell-cycle progression, and uses related thereto
11/18/1998EP0877803A1 Ob protein receptor and related compositions and methods
11/18/1998EP0877802A1 NEUROGENIC DIFFERENTIATION (NeuroD) GENES AND PROTEINS
11/18/1998EP0877798A1 Immortal human prostate epithelial cell lines and clones and their applications in the research and therapy of prostate cancer
11/18/1998EP0877796A1 Compositions and methods for mediating cell cycle progression
11/18/1998EP0877795A1 Isolation of precursor cells from hematopoietic and non-hematopoietic tissues and their use
11/18/1998EP0877760A1 Mhc complexes and uses thereof
11/18/1998EP0877759A1 Methods for increasing endogenous levels of corticotropin-releasing factor
11/18/1998EP0877758A2 PURIFIED SR-p70 PROTEIN
11/18/1998EP0877757A1 Method for evaluating and affecting male fertility
11/18/1998EP0877756A1 Anti-microbial protein
11/18/1998EP0877755A1 Two-component signal transduction response regulator polypeptides from staphylococcus aureus
11/18/1998EP0877753A1 Peptide inhibitors of hematopoietic cell proliferation
11/18/1998EP0877629A2 Lipophilic peptides for macromolecule delivery
11/18/1998EP0877627A1 Obesity protein analog compounds and formulations thereof
11/18/1998EP0877626A2 Anti-cd18 antibodies for use against stroke
11/18/1998EP0877625A1 Immunomodulatory methods using oligosaccharides
11/18/1998EP0877624A1 Streptococcal c5apeptidase vaccine
11/18/1998EP0877622A1 Method of inactivation of ras subfamily proteins and agents therefor
11/18/1998EP0877621A1 Combined pharmaceutical preparation containing lhrh-analogous substances and anti-estrogens for treating gynaecological disorders
11/18/1998EP0877620A1 Peptides for altering osteoblast adhesion
11/18/1998EP0877611A1 Hemoregulatory compounds
11/18/1998EP0877608A1 SENSITIZATION OF HER2/neu OVER-EXPRESSING CANCER CELLS TO CHEMOTHERAPEUTIC DRUGS
11/18/1998EP0877599A1 Sustained delivery of an active agent using an implantable system
11/18/1998EP0877555A1 Method of inhibiting immune system destruction of transplanted viable cells
11/18/1998EP0877549A1 Methods and compositions for the reduction of xenotransplantation rejection
11/18/1998EP0758903A4 Cryoprecipitated native fibrinogen concentrates
11/18/1998EP0732935B1 Lyophilized stem cell factor formulations
11/18/1998EP0690990B1 Parvovirus receptors and methods of use
11/18/1998EP0673254A4 6-position modified decapeptide lhrh antagonists.
11/18/1998EP0581836B1 Hybrid transposon with a pt-operon, plasmids and bacterial strains therefor
11/18/1998EP0551501B1 Use of endothelial-leukocyte adhesion molecule-1 and antibodies thereto in the treatment of asthma
11/18/1998CN1199422A Transgenic non-human animals capable of producing heterologous antibodies
11/18/1998CN1199340A Analogs of parathyroid hormone
11/18/1998CN1199097A Fused gene of IL-2 or its derivative and ANP or its derivative, three kinds of protein product thereof and their application, and vector containing said gene and construction method thereof
11/18/1998CN1198950A Preparation of medicine for colitis
11/17/1998US5837873 Intermediates of retroviral protease inhibiting compounds
11/17/1998US5837855 Rna substrates, helices for gene expression, cells, dna and genetic engineering
11/17/1998US5837854 Oligonucleotides with anti-Epstein-Barr virus activity
11/17/1998US5837852 Phosphorylated oligonucleotide use as antiinfluenza agent, enzyme inhibitor not dephosphorylated by viral polymerase and inhibitors of influenza transcription
11/17/1998US5837845 Dna encoded human monoclonal antibodies for binding antigens of stomach cancer cells
11/17/1998US5837843 Modified protein C
11/17/1998US5837842 Vascular anticoagulant proteins DNA which codes them, processer for preparing them and their use
11/17/1998US5837841 Human Reg protein
11/17/1998US5837837 Nucleic acids molecules encoding Caspase-8h and Caspase-8i
11/17/1998US5837825 Campylobacter jejuni flagellin/Escherichia coli LT-B fusion protein
11/17/1998US5837824 Binds to monoclonal antibody bw 835, dsm acc 2022; use of epitope for diagnosis and therapy
11/17/1998US5837823 Antibodies to adrenomedullin
11/17/1998US5837822 Intercellular adhesion molecule polypeptide; genetic engineering; gene expression; antiinflammatory agents
11/17/1998US5837818 Construction and expression of synthetic genes encoding envelope epitopes of the human T cell leukemia virus type I
11/17/1998US5837817 Cytoplasmic domain of tumor necrosis factor receptor and protein kinases
11/17/1998US5837816 Hetero-macromolecular coiled-complexes comprising at least three heptapeptide fusion proteins at least two are different, non-covalently binding to one another for binding interleukin in membrane
11/17/1998US5837814 Drug delivery; medical diagnosis; separations; protein fusion products
11/17/1998US5837813 Capable of inhibiting migration of tumor cells
11/17/1998US5837812 Human islet, human brain and mouse brain glutamic acid decarboxylase GAD polypeptides
11/17/1998US5837810 Polypeptides of lipopolysaccharide binding protein
11/17/1998US5837809 Mammalian opioid receptor ligand and uses
11/17/1998US5837808 Anticoagulants
11/17/1998US5837807 Dipeptides and cyclic peptide derivatives of amino tetrahydronaphthalenecarboxylic acid and helical domains
11/17/1998US5837736 Oxygen-free administration to tumors
11/17/1998US5837706 Drug for neuroprotection
11/17/1998US5837693 Intravenous hormone polypeptide delivery by salivary gland expression
11/17/1998US5837692 Inhibition of the mitogenic activity of PDGF by mammalian EGr
11/17/1998US5837688 Use of thrombolytic reagents for prevention of vascular disease
11/17/1998US5837687 Azapeptide derivative
11/17/1998US5837686 Polypeptides for antiarthritic agents
11/17/1998US5837685 Peptides from Pseudomonas syringae possessing broad-spectrum antibiotic activity
11/17/1998US5837684 Peptides
11/17/1998US5837682 Angiostatin fragments and method of use
11/17/1998US5837681 Cell degeneration in ears with administering glial cell neurotropic factor protein for hearing loss
11/17/1998US5837680 Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis
11/17/1998US5837679 Blood coagulation factor for hemophelia
11/17/1998US5837678 Therapeutic uses of bactericidal/permeability increasing protein products
11/17/1998US5837677 Method for the treatment of cancer with Exochelins of Mycobacterium tuberculosis
11/17/1998US5837676 Use of scatter factor to enhance angiogenesis
11/17/1998US5837675 Anemia therapy
11/17/1998US5837674 Administering orally or by injection; oligopeptides
11/17/1998US5837673 Camptothecin derivatives
11/17/1998US5837544 Method of inducing a cell to proliferate using a chimeric receptor comprising janus kinase
11/17/1998US5837542 Intercellular adhesion molecule-1 (ICAM-1) ribozymes
11/17/1998US5837541 Capable of protecting against bacterial infections
11/17/1998US5837540 Method of producing fibrin-specific antibodies using soluble fibrin polymers as an immunogen
11/17/1998US5837536 Expression of human multidrug resistance genes and improved selection of cells transduced with such genes
11/17/1998US5837532 Herpes simplex cirus type 1 mutant
11/17/1998US5837531 Recombinant adenoviruses for gene therapy in cancers
11/17/1998US5837525 Polypeptides
11/17/1998US5837514 Natural isolated regulatory proteins called t2k proteins (traf2-associated kinase activity)
11/17/1998US5837512 Replicates in cd4 cells that express tax protein; genetic engineering
11/17/1998US5837510 Methods and polynucleotide constructs for treating host cells for infection or hyperproliferative disorders
11/17/1998US5837507 Genetic engineering for hematopoietic stem cells
11/17/1998US5837500 Gene expression; genetic engineering; mutation
11/17/1998US5837499 Genetic engineering with polypeptides and dna molecules
11/17/1998US5837498 Corpuscles of stannius protein, stanniocalcin
11/17/1998US5837496 Promoting cell attachment to a substrate
11/17/1998US5837495 Medical diagnosis
11/17/1998US5837493 Human galectins
1 ... 2571 2572 2573 2574 2575 2576 2577 2578 2579 2580 2581 2582 2583 2584 2585 2586 2587 2588 2589 2590 2591 ... 3163